|
Shaping the Future of Respiratory Virus Research
Understanding the Transmission of Respiratory Viruses
How do we detect infections that might otherwise go unnoticed? And what can we learn about immunity where these viruses enter the body? These key questions, among many others, are expertly explored and explained by Dr Nicole Tsang and Dr Kevin Selva.
Summary report OECD/EUPHA - Long COVID Policy Dialogue
This publication is part of the “Supporting long COVID patients: insights and action initiative (2024-2026)” of the European Commission.
Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study
Long COVID is associated with worse cardiovascular fitness. Additional studies are needed to determine if Long COVID is a novel risk factor for incident CVD.
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population
Comparing the Australian and New Zealand experiences in the evolving COVID-19 landscape highlights differences in policy and prescribing practice.
Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy
Using symptom and quality of life data, clinical examinations and biofluid proteomics, authors document ocular symptoms persisting from 3 months up to 3 years post-infection.
WHO: New global youth competition on influenza and COVID-19 prevention and control
Submissions will open on Monday 3 August 2026, until Sunday 13 September 2026.
News
Scientific Papers
Reports
How benchmarking of bioinformatics tools is essential for informed workflow selection: a case study on SARS-CoV-2 sgRNA detection
New report from the Joint Research Centre (JRC)
Euronews: Trump administration pulls Covid-19 vaccine safety studies
The US FDA has halted the publication of a number of scientific studies confirming vaccine safety.